123 related articles for article (PubMed ID: 10072488)
1. Engagement of B cell receptor regulates the invariant chain-dependent MHC class II presentation pathway.
Zimmermann VS; Rovere P; Trucy J; Serre K; Machy P; Forquet F; Leserman L; Davoust J
J Immunol; 1999 Mar; 162(5):2495-502. PubMed ID: 10072488
[TBL] [Abstract][Full Text] [Related]
2. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
Forquet F; Barois N; Machy P; Trucy J; Zimmermann VS; Leserman L; Davoust J
J Immunol; 1999 Mar; 162(6):3408-16. PubMed ID: 10092796
[TBL] [Abstract][Full Text] [Related]
3. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
4. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
5. Regulation of B cell receptor-mediated MHC class II antigen processing by FcgammaRIIB1.
Wagle NM; Faassen AE; Kim JH; Pierce SK
J Immunol; 1999 Mar; 162(5):2732-40. PubMed ID: 10072518
[TBL] [Abstract][Full Text] [Related]
6. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
Ilkovitch D; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
[TBL] [Abstract][Full Text] [Related]
7. Invariant chain-independent antigen presentation depends primarily upon the pool of newly synthesized MHC class II molecules.
Swier K; Miller J
J Immunol; 1995 Aug; 155(4):1851-61. PubMed ID: 7636238
[TBL] [Abstract][Full Text] [Related]
8. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
9. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation.
Kim YM; Pan JY; Korbel GA; Peperzak V; Boes M; Ploegh HL
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3327-32. PubMed ID: 16492756
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes.
Siemasko K; Eisfelder BJ; Williamson E; Kabak S; Clark MR
J Immunol; 1998 Jun; 160(11):5203-8. PubMed ID: 9605114
[TBL] [Abstract][Full Text] [Related]
11. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells.
Kleijmeer MJ; Ossevoort MA; van Veen CJ; van Hellemond JJ; Neefjes JJ; Kast WM; Melief CJ; Geuze HJ
J Immunol; 1995 Jun; 154(11):5715-24. PubMed ID: 7751623
[TBL] [Abstract][Full Text] [Related]
12. The invariant chain induces compact forms of class II molecules localized in late endosomal compartments.
Humbert M; Raposo G; Cosson P; Reggio H; Davoust J; Salamero J
Eur J Immunol; 1993 Dec; 23(12):3158-66. PubMed ID: 8258330
[TBL] [Abstract][Full Text] [Related]
13. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
Pinet V; Malnati MS; Long EO
J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
[TBL] [Abstract][Full Text] [Related]
14. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells.
Bertolino P; Rabourdin-Combe C
Crit Rev Immunol; 1996; 16(4):359-79. PubMed ID: 8954255
[TBL] [Abstract][Full Text] [Related]
15. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents.
Humbert M; Bertolino P; Forquet F; Rabourdin-Combe C; Gerlier D; Davoust J; Salamero J
Eur J Immunol; 1993 Dec; 23(12):3167-72. PubMed ID: 8258331
[TBL] [Abstract][Full Text] [Related]
17. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
18. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
[TBL] [Abstract][Full Text] [Related]
19. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.
Serre K; Machy P; Grivel JC; Jolly G; Brun N; Barbet J; Leserman L
J Immunol; 1998 Dec; 161(11):6059-67. PubMed ID: 9834089
[TBL] [Abstract][Full Text] [Related]
20. A critical, invariant chain-independent role for H2-M in antigen presentation.
Swier K; Brown DR; Bird JJ; Martin WD; Van Kaer L; Reiner SL
J Immunol; 1998 Jan; 160(2):540-4. PubMed ID: 9551884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
